MMM vs MDLN stock comparison
3M vs. Medline · data as of November 13, 2026
3M (MMM) has a market value of about $94.9B, Medline (MDLN) about $51.9B. Over their latest twelve months 3M had revenue of $25.2B and Medline $30.7B.
On our five checks 3M scores higher: 1.4 out of 5 (weak) against 1.0 (weak).
By area, the stronger company is Medline on future growth; 3M on track record; Medline on financial health; 3M on shareholder returns.
3M is cheaper on earnings (P/E 27.4 vs. 89.7).
3M leads on 12 of the compared lines and Medline on 9.
Side by side
| MMM | MDLN | |
|---|---|---|
| Size and price | ||
| Market cap | $94.9B | $51.9B |
| Share price | $183.66 | $39.47 |
| Score | ||
| Overall score (of 5) | 1.4 | 1.0 |
| Value | 0 | 0 |
| Future growth | 1 | 2 |
| Track record | 1 | 0 |
| Financial health | 1 | 2 |
| Shareholder returns | 4 | 1 |
| Valuation | ||
| P/E (TTM) | 27.4 | 89.7 |
| Forward P/E | 19.8 | 26.2 |
| Price / free cash flow | 35.5 | 27.4 |
| Price / sales | 3.8 | 1.7 |
| EV / EBITDA | 17.1 | 22.6 |
| PEG | — | — |
| DCF value vs. price | −52% | −48% |
| Business | ||
| Revenue | $25.2B | $30.7B |
| Net income | $3.5B | $566M |
| Free cash flow | $2.7B | $1.9B |
| Net margin | 14.0% | 1.8% |
| Gross margin (5-yr avg.) | 41.3% | 26.4% |
| ROIC (5-yr avg.) | 6.8% | 8.6% |
| Growth | ||
| Revenue growth (1 yr) | 1.5% | 11.5% |
| Revenue growth (5 yrs, per year) | -5.0% | — |
| EPS growth (5 yrs, per year) | -8.5% | — |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$10.8B | -$9.1B |
| Dividend yield | 1.70% | None |
| Shareholder yield | 5.1% | 0.1% |
| Analysts | ||
| Upside to average target | +5% | +15% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: MMM TTM to September 30, 2026, MDLN TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, 3M or Medline?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) 3M scores 1.4 out of 5 and Medline 1.0; the table shows where each one is stronger.
Is 3M cheaper than Medline?
On trailing earnings, 3M trades at a P/E of 27.4 and Medline at 89.7, so 3M is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which pays a higher dividend?
3M yields 1.70% and Medline nothing (no dividend).
Full 3M analysis → Full Medline analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.